[HCV and extrahepatic manifestations].
Nagao
Yumiko
Y
Research Center for Innovative Cancer Therapy, Kurume University School of Medicine.
Sata
Michio
M
D000998:Antiviral Agents / Q000627:therapeutic use; D002353:Carrier State / Q000453:epidemiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000821:virology*; D016174:Hepacivirus / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008010:Lichen Planus / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology*; D017119:Porphyria Cutanea Tarda / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology*; D012859:Sjogren's Syndrome / Q000150:complications / Q000453:epidemiology / Q000821:virology*
D000998:Antiviral Agents; D007372:Interferons